% | $
Quotes you view appear here for quick access.

Biovest International Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • ajthedrifter ajthedrifter Feb 22, 2012 1:53 PM Flag

    Gasmanchad's Cancer Immunotherapy Index(tm)

    I cannot even consider Verastem at this point. The valuation the company received during its IPO is way above that of existing companies already 2-5 years ahead in research and clinical trials. Unless the plan of VSTM is to scoop up an existing biotech to catch up. I don't know, but my best guess is that the others in the field of researching cancer stem cells will see their market caps rise, while VSTM will remain flat.